| Literature DB >> 28933575 |
Paola Modaffari1, Marta D'alonzo1, Marta Garbagnati1, Silvia Pecchio1, Guido Menato1, Nicoletta Biglia1.
Abstract
Ulipristal acetate (UPA) has been recognized as an alternative strategy to surgery in the management of symptomatic women with uterine fibroids. We present a case report on a woman with hereditary fibrinogen deficiency exclusively treated with UPA for myoma-related menorrhagia and abdominal pain, who subsequently underwent a hysterectomy because of clinical worsening. A FIGO IB uterine leiomyosarcoma was found among multiple myomas. A review of the literature found two other cases of uterine leiomyosarcoma in patients treated with UPA: clinical data are reported. The aim of this case report is to increase clinicians' awareness that, although rare, leiomyosarcoma can develop in a uterus with multiple myomas and no reliable diagnostic tools exist yet. Thus, a clinical and instrumental careful reevaluation and patient counseling should be a priority when planning to repeat UPA treatment cycles.Entities:
Keywords: ulipristal acetate; uterine leiomyosarcoma; uterine myoma
Mesh:
Substances:
Year: 2017 PMID: 28933575 DOI: 10.1080/09513590.2017.1380186
Source DB: PubMed Journal: Gynecol Endocrinol ISSN: 0951-3590 Impact factor: 2.260